-
Innovation Ranking
NewInnovation Ranking – Hunan Er-Kang Pharmaceutical Co Ltd
Hunan Er-Kang Pharmaceutical Co Ltd (Hunan Er-Kang) is a provider of the development, production and sale of pharmaceutical drugs and active pharmaceutical ingredients. The company's products include aminocaproic acid injection, aminophylline injection, sulfoethylamine injection, sulfadiazine sodium injection, chlorpheniramine maleate injection, and tobramycin sulfate injection, vitamin B6 Injection, chlorpheniramine maleate tablets, ganmaoling granules, aminojia huangmin capsules, Sulfenbenicillin Sodium for Injection and compound licorice tablets among others. Hunan Er-Kang is headquartered in Changsha City, Hunan, China.
-
Product Insights
Chek Kang- Suntech Solar Installation
Chek Kang- Suntech Solar Installation is a solar PV project located in Tibet Autonomous Region, China. The project was developed by Wuxi Suntech Power Co Ltd. The project is currently active. Empower your strategies with our Chek Kang- Suntech Solar Installation report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
Henan Tai Kang Chen Feng
Henan Tai Kang Chen Feng is an Onshore Wind project located in Henan, China. The project is owned by China General Nuclear Power Corp Ltd; Sembcorp Industries Ltd and was developed by China General Nuclear Power Corp Ltd. The project came online in 2020. Empower your strategies with our Henan Tai Kang Chen Feng report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2...
-
Product Insights
Kaposi Sarcoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Kaposi Sarcoma - Drugs In Development, 2023’, provides an overview of the Kaposi Sarcoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Kaposi Sarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Gastrointestinal Stromal Tumor (GIST) – Drugs In Development, 2023
Global Markets Direct’s, ‘Gastrointestinal Stromal Tumor (GIST) - Drugs In Development, 2023’, provides an overview of the Gastrointestinal Stromal Tumor (GIST) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gastrointestinal Stromal Tumor (GIST), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Mesenchymal Tumor Of The Gastrointestinal Tract – Drugs In Development, 2023
Global Markets Direct’s, ‘Mesenchymal Tumor Of The Gastrointestinal Tract - Drugs In Development, 2023’, provides an overview of the Mesenchymal Tumor Of The Gastrointestinal Tract pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mesenchymal Tumor Of The Gastrointestinal Tract, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Leukocyte Disorders (White Blood Cell Disorders) – Drugs In Development, 2023
Global Markets Direct’s, ‘Leukocyte Disorders (White Blood Cell Disorders) - Drugs In Development, 2023’, provides an overview of the Leukocyte Disorders (White Blood Cell Disorders) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leukocyte Disorders (White Blood Cell Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Mesenchymal Tumor – Drugs In Development, 2023
Global Markets Direct’s, ‘Mesenchymal Tumor - Drugs In Development, 2023’, provides an overview of the Mesenchymal Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mesenchymal Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Thrombocytopenia – Drugs In Development, 2023
Global Markets Direct’s, ‘Thrombocytopenia - Drugs In Development, 2023’, provides an overview of the Thrombocytopenia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thrombocytopenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
MORTH India – Kahlwan to Kang Sahbu Road – Punjab
Equip yourself with the essential tools needed to make informed and profitable decisions with our MORTH India - Kahlwan to Kang Sahbu Road - Punjab report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...